Oxytocin and social functioning in people at high risk for psychosis

  • Research type

    Research Study

  • Full title

    Neurophysiological basis of effects of oxytocin on emotional processing and social cognition in people at ultra high risk for psychosis.

  • IRAS ID

    150687

  • Contact name

    Paolo Fusar-Poli

  • Contact email

    paolo.fusar-poli@kcl.ac.uk

  • Research summary

    Psychotic disorders are usually preceded by a prodromal phase (Ultra High Risk Mental State) characterised by attenuated psychotic symptoms, emotional dysregulation and difficulties with interpersonal relationships. Emotional and social cognition problems are common in UHR individuals, are the main source of their distress, and are a key factor in the associated loss of vocational function. Administration of oxytocin (OT) appears to promote social interactions and emotional bonding in healthy volunteers, improve emotional and social dysfunction, and ameliorate psychotic symptoms in patients with schizophrenia. The present study will evaluate the mechanism of action of OT on social cognition and emotional processing in UHR individuals. They will enter a double blind randomized OT vs placebo acute single-dose challenge in a cross over design. During each OT/placebo challenge we will use functional magnetic resonance imaging (fMRI) and eye-tracking to measure the effects of OT on the neural substrates of emotional processing and social cognition. Subjects will also undergo clinical assessment with standardized psychometric scales.

  • REC name

    London - London Bridge Research Ethics Committee

  • REC reference

    14/LO/1692

  • Date of REC Opinion

    12 Nov 2014

  • REC opinion

    Further Information Favourable Opinion